| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BSX | Common Stock | Purchase | $4.51K | +50 | +0.03% | $90.29 | 148K | Dec 3, 2024 | Direct | F1 |
| transaction | BSX | Common Stock | Sale | -$1.8K | -20 | -0.01% | $89.97 | 148K | Dec 10, 2024 | Direct | F1 |
| transaction | BSX | Common Stock | Award | $0 | +31.7K | +20.36% | $0.00 | 187K | Feb 11, 2025 | Direct | F2 |
| transaction | BSX | Common Stock | Tax liability | -$1.53M | -14.4K | -7.71% | $105.98 | 173K | Feb 11, 2025 | Direct | |
| holding | BSX | Common Stock | 4.89K | Dec 3, 2024 | By Child | F3 |
| Id | Content |
|---|---|
| F1 | This transaction was inadvertently effected by a broker through a broker managed account, without any instruction from or knowledge of the reporting person. |
| F2 | On February 16, 2022, the reporting person was awarded a target number of performance share units under the Company's 2022 Total Shareholder Return Performance Share Program, with the actual number to be earned by the reporting person to be based on the Company's total shareholder return performance percentile relative to that of the other companies in the S&P 500 Health Care Index over the three-year performance cycle comprising the three-year period ended December 31, 2024 and subject to the completion of the concurrent three-year individual service period. On February 11, 2025, the number of performance share units as to which the performance criteria had been satisfied was determined and the individual service period was satisfied. |
| F3 | The reporting person disclaims beneficial ownership of the shares held by his child, and this report should not be deemed an admission that the reporting person is the beneficial owner of his child's shares for purposes of Section 16 or for any other purpose. |